|
|
| Home > Products |
 |
|
 |
| |
| Product Name |
CAS Number |
Download |
|
12,13-dimethyl-12,13-dihydro-5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione
|
|
PDF
|
|
1,2,3,4,5-penta-o-benzyl-1-c-(2,6-dioxopiperidin-4-yl)pentitol
|
|
PDF
|
|
(7ar,8r,8as,15ar,15bs)-15b-hydroxy-8-phenyl-7,7a,8,8a,15a,15b-hexahydro-5h-dibenzo[b',f]cyclopenta[1,5-c:2,3-d']bisazepine-6,9,15(14h)-trione
|
|
PDF
|
|
13,14-dimethyl-6,7,13,14-tetrahydroindolo[2,3-a]pyridazino[4,5-c]carbazole-5,8-dione
|
|
PDF
|
|
12,15,15b,17b-tetramethyl-9-oxo-2,3,4,4a,5,6,6a,6b,7,7a,11,12,13,15,15a,15b,16,17,17a,17b-icosahydro-1h-naphtho[2',1':4,5]indeno[1,2-f]pyrido[1,2-c][1,3]oxazepin-3-yl acetate
|
|
PDF
|
|
4,4,14-trimethyl-24-oxo-16,24-epoxy-9,19-cyclocholan-3-yl acetate
|
|
PDF
|
|
tert-butyl(9r,10r)-4,8,8-trimethyl-2-oxo-9,10-bis{[(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]hept-1-yl)carbonyl]oxy}-9,10-dihydro-2h-pyrano[2,3-h]quinoline-1(8h)-carboxylate
|
|
PDF
|
|
(9r,10r)-3,4,8,8-tetramethyl-2-oxo-1,8,9,10-tetrahydro-2h-pyrano[2,3-h]quinoline-9,10-diyl bis(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate)
|
|
PDF
|
|
1-(4-Chloro-benzyl)-5-fluoro-2,3-dihydro-1H-indol-3-ylamine2HClsalt
|
|
PDF
|
|
(9r,10r)-4,8,8-trimethyl-2-oxo-1,8,9,10-tetrahydro-2h-pyrano[2,3-h]quinoline-9,10-diyl bis(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate)
|
|
PDF
|
|
(9r,10r)-4,6,8,8-tetramethyl-2-oxo-9,10-dihydro-2h,8h-pyrano[2,3-f]chromene-9,10-diyl bis(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate)
|
|
PDF
|
|
(9r,10r)-5,8,8-trimethyl-2-oxo-4-(propan-2-yl)-9,10-dihydro-2h,8h-pyrano[2,3-f]chromene-9,10-diyl bis(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate)
|
|
PDF
|
|
(9r,10r)-8,8-dimethyl-4-oxo-9,10-dihydro-4h,8h-pyrano[2,3-f]chromene-9,10-diyl bis(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate)
|
|
PDF
|
|
(9r,10r)-3-(dibromomethyl)-8,8-dimethyl-2-oxo-9,10-dihydro-2h,8h-pyrano[2,3-f]chromene-9,10-diyl bis(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate)
|
|
PDF
|
|
|
| |
 |
|
 |
|
|
|
|
| |
|
|
